MAINZ BIOMED
Mainz BioMed develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. Mainz Bio is Specializing in the early detection of cancer with it's flagship product COloAlert.
MAINZ BIOMED
Social Links:
Industry:
Biotechnology
Founded:
2021-01-01
Address:
Mainz, Rheinland-Pfalz, Germany
Country:
Germany
Website Url:
http://www.mainzbiomed.com
Total Employee:
11+
Status:
Active
Contact:
+49 (0) 6131 / 55428-60
Email Addresses:
[email protected]
Total Funding:
22.5 M USD
Technology used in webpage:
Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Person Schema COVID-19
Similar Organizations
Dxcover
The Future of Cancer Diagnostics
GNA Biosolutions
GNA Biosolutions is a private molecular diagnostics company.
Molbio Diagnostics
Molbio Diagnostics is a molecular diagnostics manufacturer.
NuProbe
NuProbe is a cutting-edge genomics and molecular diagnostics company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Sense Biodetection
Sense Biodetection Limited is a molecular diagnostics company .
Singleron Biotechnologies
Singleron Biotechnologies is an innovative molecular diagnostic company.
CareDx
CareDx is a novel molecular diagnostics company.
Current Employees Featured
Founder
Stock Details
Key Employee Changes
Official Site Inspections
http://www.mainzbiomed.com Semrush global rank: 9.08 M Semrush visits lastest month: 218
Unable to get host informations!!!
More informations about "Mainz Biomed"
Our Company - Mainz Biomed
†Approved for sale in EU *Dollinger MM et al. (2018), ClinLab 64 (10), 1719-1730; internal data comparing ColoAlert to FIT. NOTE: the globally most-used non-invasive test for screening …See details»
Group - Mainz Biomed
Mainz Biomed Group To be effective, cancer detection needs to be simple, readily available, and affordable. We develop innovative products that quickly and reliably identify the early onset of …See details»
Mainz Biomed - Crunchbase Company Profile & Funding
Mainz BioMed is a molecular genetic diagnostics company developing market-ready molecular genetic diagnostic solutions.See details»
Mainz Biomed - LinkedIn
Mainz Biomed is aiming to become a leading provider of easy-to-use diagnostic solutions for patients everywhere. We develop innovative products that quickly and easily identify the early onset of ...See details»
Mainz Biomed (MYNZ) Company Profile & Description - Stock …
Nov 5, 2021 Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer …See details»
Mainz BioMed - Craft
Oct 29, 2024 Mainz BioMed is a molecular genetics cancer diagnostic company that manufactures in-vitro diagnostic (IVD) tests. It offers ColoAlert, a colorectal cancer screening …See details»
Mainz BioMed | Mainz - Facebook
How Mainz Biomed is Leading the Charge in Cancer Detection: Key 2024 Highlights In 2024, Mainz Biomed made strides with a Lab network revenue increased by 33% year over year and reduced operational loss by 30%.See details»
Company Mainz Biomed N.V. - MarketScreener.com
Jun 30, 2021 Mainz Biomed N.V.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: MYNZ | NasdaqSee details»
Investors - Mainz Biomed
Oct 28, 2021 Mainz Biomed Investor Information, Corporate Presentation and Corporate FilingsSee details»
Mainz BioMed
97% sensitivity for colorectal cancer and 82% for advanced precancerous lesions for their next generation product. These results are so groundbreaking in the industry that they pave the …See details»
The Journey of Mainz BioMed: From Start-up to a NASDAQ Listing
Mar 21, 2024 So I I spent many years in this technology, again, in a large organization with Roche. And afterwards, joined a small world, companies. Guido Baechler CEO Mainz BioMed …See details»
Mainz Biomed - Overview, News & Similar companies - ZoomInfo
View Mainz Biomed (www.mainzbiomed.com) location in Rheinland-Pfalz, Germany , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Mainz Biomed Expands into Switzerland with labor team w
Feb 20, 2025 MC Services AG Anne Hennecke/Simone Neeten +49 211 529252 22 [email protected] For investor inquiries, please contact [email protected] …See details»
Mainz BioMed - 2025 Company Profile - Tracxn
Apr 3, 2025 Mainz BioMed is a public company based in Mainz (Germany), founded in 2021.It operates as a Provider of diagnostic kits for colorectal cancer.Mainz BioMed has raised an …See details»
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes …
Oct 1, 2024 BERKELEY, Calif. and MAINZ, Germany, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular …See details»
OUR BUSINESS - Mainz Biomed
OUR BUSINESS CONCEPT & PIPELINE SAVES LIVES AND HEALTH CARE COSTS $38,469Avg. 1-year cost of CRC treatment 9 Ongoing testing every 3 years Pathway to …See details»
Mainz Biomed Enters into Technology Partnership with EDX …
Apr 29, 2025 For investor inquiries, please contact [email protected]. For media inquiries as to EDX Medical Group: Media House International Ramsay Smith +44 (0)7788 414856 …See details»
Mainz Biomed Provides First Quarter 2025 Corporate Update and …
BERKELEY, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company …See details»
Mainz Biomed Reports 2024 Financial Results and Provides …
Apr 1, 2025 For investor inquiries, please contact [email protected]. Forward-Looking Statements Certain statements made in this press release are “forward-looking statements” …See details»
Mainz Biomed Establishes Partnership with Precision for
Nov 30, 2021 For more information please visit www.mainzbiomed.com. ... Precision for Medicine is the first biomarker-driven clinical research services organization supporting life …See details»